3-(1-methylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;tris(3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene);3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tetrakis(platinum(2+));3-(1-propan-2-ylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene

C81H72F9N39Pt4 — CID 161409985

About 3-(1-methylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;tris(3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene);3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tetrakis(platinum(2+));3-(1-propan-2-ylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene

3-(1-methylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;tris(3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene);3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tetrakis(platinum(2+));3-(1-propan-2-ylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene (PubChem CID 161409985) has the molecular formula C81H72F9N39Pt4 and a molecular weight of 2543.03 g/mol. Its IUPAC name is 3-(1-methylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;tris(3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene);3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tetrakis(platinum(2+));3-(1-propan-2-ylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene.

Molecular Properties

• Compound Name: 3-(1-methylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;tris(3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene);3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tetrakis(platinum(2+));3-(1-propan-2-ylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene
• PubChem CID: 161409985
• Molecular Formula: C81H72F9N39Pt4
• Molecular Weight: 2543.03 g/mol
• Exact Mass: 2541.53
• IUPAC Name: 3-(1-methylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;tris(3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene);3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tetrakis(platinum(2+));3-(1-propan-2-ylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene
• SMILES: CC(C)n1ccnc1-c1nc(C(F)(F)F)n[n-]1.Cc1n[n-]c(-c2nccn2-c2ccccc2)n1.Cc1n[n-]c(-c2nccn2-c2ccccc2)n1.Cc1n[n-]c(-c2nccn2-c2ccccc2)n1.Cc1n[n-]c(-c2nccn2C(C)C)n1.Cc1n[n-]c(-c2nccn2C)n1.Cn1ccnc1-c1nc(C(F)(F)F)n[n-]1.FC(F)(F)c1cc(-c2nccn2-c2ccccc2)[n-]n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2]
• InChI: InChI=1S/C13H8F3N4.3C12H10N5.C9H9F3N5.C9H12N5.C7H5F3N5.C7H8N5.4Pt/c14-13(15,16)11-8-10(18-19-11)12-17-6-7-20(12)9-4-2-1-3-5-9;3*1-9-14-11(16-15-9)12-13-7-8-17(12)10-5-3-2-4-6-10;1-5(2)17-4-3-13-7(17)6-14-8(16-15-6)9(10,11)12;1-6(2)14-5-4-10-9(14)8-11-7(3)12-13-8;1-15-3-2-11-5(15)4-12-6(14-13-4)7(8,9)10;1-5-9-6(11-10-5)7-8-3-4-12(7)2;;;;/h1-8H;3*2-8H,1H3;3-5H,1-2H3;4-6H,1-3H3;2-3H,1H3;3-4H,1-2H3;;;;/q8*-1;4*+2
• InChIKey: VVIKMLPTPGPMDH-UHFFFAOYSA-N
• XLogP: 11.76
• TPSA: 448.71 Ų
• H-Bond Acceptors: 31
• Rotatable Bonds: 14
• Heavy Atoms: 133
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2543.03
LogP ≤ 5	11.76
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	31

Frequently Asked Questions

What is the IUPAC name of 3-(1-methylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;tris(3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene);3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tetrakis(platinum(2+));3-(1-propan-2-ylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene?

The IUPAC name of 3-(1-methylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;tris(3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene);3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tetrakis(platinum(2+));3-(1-propan-2-ylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene (CID 161409985) is 3-(1-methylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;tris(3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene);3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tetrakis(platinum(2+));3-(1-propan-2-ylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene.

What is the SMILES notation for 3-(1-methylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;tris(3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene);3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tetrakis(platinum(2+));3-(1-propan-2-ylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene?

The canonical SMILES for 3-(1-methylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;tris(3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene);3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tetrakis(platinum(2+));3-(1-propan-2-ylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene is CC(C)n1ccnc1-c1nc(C(F)(F)F)n[n-]1.Cc1n[n-]c(-c2nccn2-c2ccccc2)n1.Cc1n[n-]c(-c2nccn2-c2ccccc2)n1.Cc1n[n-]c(-c2nccn2-c2ccccc2)n1.Cc1n[n-]c(-c2nccn2C(C)C)n1.Cc1n[n-]c(-c2nccn2C)n1.Cn1ccnc1-c1nc(C(F)(F)F)n[n-]1.FC(F)(F)c1cc(-c2nccn2-c2ccccc2)[n-]n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].

What is the InChIKey of 3-(1-methylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;tris(3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene);3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tetrakis(platinum(2+));3-(1-propan-2-ylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene?

The InChIKey is VVIKMLPTPGPMDH-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H8F3N4.3C12H10N5.C9H9F3N5.C9H12N5.C7H5F3N5.C7H8N5.4Pt/c14-13(15,16)11-8-10(18-19-11)12-17-6-7-20(12)9-4-2-1-3-5-9;3*1-9-14-11(16-15-9)12-13-7-8-17(12)10-5-3-2-4-6-10;1-5(2)17-4-3-13-7(17)6-14-8(16-15-6)9(10,11)12;1-6(2)14-5-4-10-9(14)8-11-7(3)12-13-8;1-15-3-2-11-5(15)4-12-6(14-13-4)7(8,9)10;1-5-9-6(11-10-5)7-8-3-4-12(7)2;;;;/h1-8H;3*2-8H,1H3;3-5H,1-2H3;4-6H,1-3H3;2-3H,1H3;3-4H,1-2H3;;;;/q8*-1;4*+2.

What are the key properties of 3-(1-methylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;tris(3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene);3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tetrakis(platinum(2+));3-(1-propan-2-ylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene?

3-(1-methylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;tris(3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene);3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tetrakis(platinum(2+));3-(1-propan-2-ylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene has a molecular weight of 2543.03 g/mol, XLogP of 11.76, 14 rotatable bonds, 0 hydrogen bond donors, and 31 hydrogen bond acceptors.

Where does this data come from?

All data for 3-(1-methylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;3-methyl-5-(1-methylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;tris(3-methyl-5-(1-phenylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene);3-methyl-5-(1-propan-2-ylimidazol-2-yl)-2,4-diaza-1-azanidacyclopenta-2,4-diene;5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide;tetrakis(platinum(2+));3-(1-propan-2-ylimidazol-2-yl)-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene is sourced from PubChem (CID 161409985), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).